Showing results (1591-1600 of 1,690) with videos related to
Sort By:
Pageof 169
BMJ (Clinical Research Ed.)|April 6, 2023
Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trialsQingyang Shi, Kailei Nong, Per Olav Vandvik, et al.Annals of Internal Medicine|December 24, 2019
Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery: A Cohort StudyEmmanuelle Duceppe, Ameen Patel, Matthew T V Chan, et al.Arthritis Care & Research|July 8, 2021
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated VasculitisSharon A Chung, Carol A Langford, Mehrdad Maz, et al.JMIR Research Protocols|April 14, 2022
Lessening Organ Dysfunction With Vitamin C (LOVIT) Trial: Statistical Analysis PlanNeill Kj Adhikari, Ruxandra Pinto, Andrew G Day, et al.Journal of Clinical Epidemiology|April 30, 2013
The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence synthesesReem A Mustafa, Nancy Santesso, Jan Brozek, et al.JAMA|December 19, 2018
Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysisJason W Busse, Li Wang, Mostafa Kamaleldin, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 8, 2021
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu ArteritisMehrdad Maz, Sharon A Chung, Andy Abril, et al.Arthritis Care & Research|July 8, 2021
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis NodosaSharon A Chung, Mark Gorelik, Carol A Langford, et al.BMJ (Clinical Research Ed.)|September 24, 2021
Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysisReed Ac Siemieniuk, Jessica J Bartoszko, Juan Pablo Díaz Martinez, et al.JAMA|March 13, 2014
Prevalence, characteristics, and publication of discontinued randomized trialsBenjamin Kasenda, Erik von Elm, John You, et al.Pageof 169